TNF and cancer: As shown in Table 1, the mean age of patients at TNF inhibitor initiation was 39.2 ± 13.0 years; 75.9% were male, 90.1% were HLA-B27-positive, approximately half were ever smokers, and 2.8% had a history of cancer.